Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT05799820
Eligibility Criteria:
Inclusion Criteria:
* 1\. Subjects participate voluntarily and sign informed consent.
* 2\. Age ≥ 18 and ≤ 80 years old, male or female.
* 3\. Histologically confirmed unresectable locally advanced or metastatic adenocarcinoma of the colon or rectum.
* 4\. At least 1 measurable target lesion according to Response Evaluation in Solid Tumors (RECIST 1.1).
Exclusion Criteria:
* 1\. Diagnosed additional maliganancy within 5 years with the expection of curatively treated basal cell carcinoma of the skin, squamous cell carcinoma of the skin,curatively resected in situ cervival or non-muscle invasive bladder cancers.
* 2\. Presence of brain metastases (asymptomatic brain metastases or symptomatic brain metastases who are stable at least 4 weeks, were allowed to be enrolled).
* 3\. Has active autoimmune disease that has required systemic treatment in past 2 years.
* 4\. Significant cardiovascular disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05799820
Study Brief:
Protocol Section:
NCT05799820